A citation-based method for searching scientific literature

Tetsuhiro Owaki, Yuko Kijima, Heiji Yoshinaka, Yoshikazu Uenosono, Takako Yoshioka, Shoji Natsugoe, Takashi Aikou. Breast Cancer 2006
Times Cited: 6







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
348
83

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
298
50

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
207
33


Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
121
33

Positron emission tomography in breast cancer: a clinicopathological correlation of results.
A Y Rostom, J Powe, A Kandil, A Ezzat, S Bakheet, F el-Khwsky, G el-Hussainy, R Sorbris, O Sjoklint. Br J Radiol 1999
55
33

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
248
33

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
N Avril, J Dose, F Jänicke, S Bense, S Ziegler, C Laubenbacher, W Römer, H Pache, M Herz, B Allgayer,[...]. J Clin Oncol 1996
189
33

Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Asako Azuma, Mitsuhiro Tozaki, Kensuke Ito, Eisuke Fukuma, Tomoko Tanaka, Toshihiro O'uchi. Radiat Med 2008
11
33

Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
382
33


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
204
33

Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Hideo Shigematsu, Takayuki Kadoya, Norio Masumoto, Kazuo Matsuura, Akiko Emi, Keiko Kajitani, Ai Amioka, Morihito Okada. Clin Breast Cancer 2014
10
33


Lymphedema: strategies for management.
S R Cohen, D K Payne, R S Tunkel. Cancer 2001
63
16

Nonpalpable mammographically occult invasive breast cancers detected by MRI.
Lia Bartella, Laura Liberman, Elizabeth A Morris, D David Dershaw. AJR Am J Roentgenol 2006
47
16


Lymphatic disorders in rheumatoid arthritis.
E Joos, P Bourgeois, J P Famaey. Semin Arthritis Rheum 1993
18
16

High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
139
16



Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
999
16

Long-term complications associated with breast-conservation surgery and radiotherapy.
Funda Meric, Thomas A Buchholz, Nadeem Q Mirza, Georges Vlastos, Frederick C Ames, Merrick I Ross, Raphael E Pollock, S Eva Singletary, Barry W Feig, Henry M Kuerer,[...]. Ann Surg Oncol 2002
127
16

[Retroperitoneal fibrosis secondary to metastatic neoplasm revealed by a leg lymphedema].
N Foureur, V Descamps, B Lebrun-Vignes, M Grossin, C Picard-Dahan, V Lecerf, S Belaich, B Crickx. Ann Dermatol Venereol 2002
4
25


Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients.
S Barete, V Calvez, C Mouquet, B Barrou, H Kreis, J Dantal, R Dorent, F Durand, Y Dimitrov, N Dupin,[...]. Arch Dermatol 2000
42
16

Lymphedema after treatment of breast cancer.
Cihangir Ozaslan, Bekir Kuru. Am J Surg 2004
150
16

Measurement of lower leg compression in vivo: recommendations for the performance of measurements of interface pressure and stiffness: consensus statement.
Hugo Partsch, Michael Clark, Sophie Bassez, Jean-Patrick Benigni, Francis Becker, Vladimir Blazek, Joseph Caprini, André Cornu-Thénard, Jürg Hafner, Mieke Flour,[...]. Dermatol Surg 2006
128
16


Magnetic resonance imaging in breast cancer.
M Van Goethem, W Tjalma, K Schelfout, I Verslegers, I Biltjes, P Parizel. Eur J Surg Oncol 2006
49
16

MR imaging of the breast in patients with occult primary breast carcinoma.
E A Morris, L H Schwartz, D D Dershaw, K J van Zee, A F Abramson, L Liberman. Radiology 1997
129
16

Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
J A Olson, E A Morris, K J Van Zee, D C Linehan, P I Borgen. Ann Surg Oncol 2000
95
16

MR imaging of ductal carcinoma in situ.
S G Orel, M H Mendonca, C Reynolds, M D Schnall, L J Solin, D C Sullivan. Radiology 1997
196
16

MRI in patients with axillary metastases of occult breast carcinoma.
M M Tilanus-Linthorst, A I Obdeijn, M Bontenbal, M Oudkerk. Breast Cancer Res Treat 1997
38
16

Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
C Walter, K Scheidhauer, A Scharl, U-J Goering, P Theissen, H Kugel, T Krahe, U Pietrzyk. Eur Radiol 2003
46
16

Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
Jacobus J M van der Hoeven, Otto S Hoekstra, Emile F I Comans, Rik Pijpers, Robert P A Boom, Dick van Geldere, Sybren Meijer, Adriaan A Lammertsma, Gerrit J J Teule. Ann Surg 2002
80
16


Occult primary adenocarcinoma with axillary metastases.
M M Kemeny, D E Rivera, J J Terz, J R Benfield. Am J Surg 1986
56
16

Occult breast carcinoma presenting as an axillary mass.
C R Scoggins, J V Vitola, M P Sandler, J B Atkinson, M Frexes-Steed. Am Surg 1999
16
16

Surgical significance of isolated axillary adenopathy.
M B DOCKERTY, H K GRAY, E H PIERCE. Ann Surg 1957
26
16

Contrast-enhanced computed tomography detection of occult breast cancers presenting as axillary masses.
S Akashi-Tanaka, T Fukutomi, K Miyakawa, N Uchiyama, T Nanasawa, H Tsuda. Breast Cancer Res Treat 1999
8
16

Occult breast cancer presenting with axillary metastases. Updated management.
P L Baron, M P Moore, D W Kinne, F C Candela, M P Osborne, J A Petrek. Arch Surg 1990
119
16

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.
I de Mascarel, F Bonichon, G MacGrogan, C T de Lara, A Avril, V Picot, M Durand, L Mauriac, M Trojani, J M Coindre. Breast Cancer Res Treat 2000
42
16


Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
Laura J Esserman, Anjali S Kumar, Alex F Herrera, Jessica Leung, Alfred Au, Yunn-Yi Chen, Dan H Moore, Daniel F Chen, Jennifer Hellawell, Dulcy Wolverton,[...]. J Clin Oncol 2006
88
16


Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
111
16

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Ke-Da Yu, La-Mu Wu, Guang-Yu Liu, Jiong Wu, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao. Ann Surg Oncol 2011
45
16

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.
Yasuhiro Okumura, Yutaka Yamamoto, Zhenhuan Zhang, Tatsuya Toyama, Teru Kawasoe, Mutsuko Ibusuki, Yumi Honda, Ken-ichi Iyama, Hiroko Yamashita, Hirotaka Iwase. BMC Cancer 2008
22
16

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Sevilay Altintas, Kathleen Lambein, Manon T Huizing, Geert Braems, Fernando Tjin Asjoe, Hilde Hellemans, Eric Van Marck, Joost Weyler, Marleen Praet, Rudy Van den Broecke,[...]. Breast J 2009
33
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.